Investigation of efficacy and safety of insulin degludec or insulin glargine in type 2 diabetes with basal-bolus therapy

Trial Profile

Investigation of efficacy and safety of insulin degludec or insulin glargine in type 2 diabetes with basal-bolus therapy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Insulin degludec (Primary) ; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms JUN-SIBA study
  • Most Recent Events

    • 02 Nov 2014 Status changed from recruiting to discontinued as reported by UMIN record.
    • 02 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top